First Iranian COVID-19 vaccine starts clinical trial
By:
BLACKSEA-CASPIA
Phase 2 and 3 of clinical trial for the first Iranian coronavirus vaccine, COVIran Barakat, began on Monday with two voluntary receivers.
Moradvand, cardiologist, and Rasoulinejad, infectious disease specialist, are the two lecturers of Tehran University Medical Sciences who volunteered to receive the vaccine to begin phase 2 and 3 of its clinical trial.